NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma

Clinical trial NCT05024318 · UNKNOWN

Trial details

NCT number: NCT05024318
Sponsor: Peter MacCallum Cancer Centre, Australia
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma, Clear Cell, Somatic

Start date: 2022-02-08
Primary completion: 2025-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.